Insider Transactions in Q1 2024 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Kevin J. Ballinger |
BUY
Open market or private purchase
|
Direct |
11,700
+39.65%
|
$187,200
$16.99 P/Share
|
|
Mar 05
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
3,800
-1.81%
|
$64,600
$17.17 P/Share
|
|
Mar 05
2024
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,877
-1.93%
|
$167,909
$17.17 P/Share
|
|
Mar 05
2024
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,481
-1.87%
|
$93,177
$17.17 P/Share
|
|
Mar 05
2024
|
Marie L. Jones VP, Finance and CAO |
SELL
Open market or private sale
|
Direct |
2,602
-3.27%
|
$44,234
$17.17 P/Share
|
|
Mar 05
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
2,497
-1.49%
|
$42,449
$17.17 P/Share
|
|
Mar 01
2024
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
74,954
+12.8%
|
-
|
|
Mar 01
2024
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,201
+17.5%
|
-
|
|
Mar 01
2024
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
24,555
+23.6%
|
-
|
|
Mar 01
2024
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
42,818
+20.34%
|
-
|
|
Mar 01
2024
|
Chas Mc Khann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,313
+13.25%
|
-
|
|
Mar 01
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
38,674
+15.58%
|
-
|
|
Feb 29
2024
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
3,000
-1.73%
|
$66,000
$22.25 P/Share
|